Results Healthcare is delighted to announce that it has advised Prescient Healthcare Group, a leading product strategy consultancy to the global biopharmaceutical industry, on securing growth equity investment from Baird Capital.
Founded in 2007, Prescient is headquartered in London with offices in the US, India and China. The business provides decision support services to help its clients make better clinical and commercial decisions resulting in enhanced outcomes for patients, customers and shareholders. Prescient partners with many of the leading multinational pharmaceutical companies, as well as a growing number of emerging biotech organisations.
The management team of Prescient engaged Results Healthcare to help them find a partner to support their growth and investment in innovative new products. Results acted as sole financial advisor on the transaction.
Prescient Healthcare Group CEO Jamie Denison-Pender:
“Results Healthcare came highly recommended to us and they didn’t disappoint. Having not gone through such a process before, Results played a critical role in ensuring we found the right partner to grow our business. They are extremely well connected within the healthcare services space and were perfectly positioned to advise on the cultural and strategic fit of the various suiters. They also gave us huge confidence that the deal was structured in such a way that aligned the interests of both the management team and the investor. In summary, they were a pleasure to work with and I’d advise any CEO looking to embark on a similar journey to give Results a call.”